Healthcare Reports

Trends, opportunity and forecast in heart failure drug market in Canada to 2030 by drug type (ace inhibitors, angiotensin receptor blockers, beta blockers, diuretics, and others), application (injection, capsule, and tablets), end use (hospitals, specialty centres, and others), and distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies).

Trends, opportunity and forecast in veterinary medication market in Canada to 2030 by product (drugs, vaccines, and medicated feed additives), route of administration (oral route, parenteral route, and topical route), distribution channel (veterinary hospitals pharmacies and retail veterinary pharmacies), and animal type (companion animals and livestock animals).

Trends, opportunity and forecast in livestock vaccine market in Canada to 2030 by product type (bovine vaccine, poultry vaccine, porcine vaccine, and others), and technology (live attenuated vaccine, inactivated vaccine, toxoid vaccine, recombinant vaccine, and others).

This market report covers trends, opportunities, and forecasts in the antidepressant market in Canada to 2031 by product (tricyclic antidepressants, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, monoamine oxidase inhibitors, serotonin antagonist & reuptake inhibitors, and others), and depressive disorder (major depressive disorder, obsessive-compulsive disorder, generalized anxiety disorder, panic disorder, and others)

This market report covers trends, opportunities, and forecasts in the inactivated vaccine market in Canada to 2031 by type (viral, bacterial, and others) and end use (hospitals, homecare, specialty clinics, and others)

This market report covers trends, opportunities and forecasts in anticancer drug market in Canada to 2035 by type (targeted drugs, cytotoxic drugs, hormonal drugs, and others) and application (immunotherapy, targeted therapy, chemotherapy, hormonal thera

This market report covers trends, opportunities, and forecasts in the neuropathic pain drug market in Canada to 2031 by drug class (antidepressants, anticonvulsant, opioids, capsaicin, and others), indication (diabetic neuropathy, spinal stenosis, chemotherapy-induced peripheral neuropathy, and others), and distribution channel (hospital pharmacies, drugs stores and retail pharmacies, and online pharmacies)

This market report covers trends, opportunities, and forecasts in the short acting nicotine replacement therapy market in Canada to 2031 by type (nicotine gum, nicotine lozenge, nasal spray, oral inhaler, and nicotine pouches), and application (online sal

This market report covers trends, opportunities and forecasts in propofol drug market in Canada to 2031 by type (10 mL, 20 mL, 50 mL, and 100 mL) and application (general anesthesia, medical procedures sedation, mechanical ventilation, and others)

This market report covers trends, opportunities, and forecasts in the antitumor peptide drug market in Canada to 2031 by type (lanreotide, octreotide, goserelin, leuprolide, and degarelix), and application (hospital, clinic, and others)

This market report covers trends, opportunity and forecast in allergic rhinitis immunotherapy market in Canada to 2035 by type (seasonal allergic rhinitis, perennial allergic rhinitis, and occupational allergic rhinitis) and application (antihistamines,

This market report covers trends, opportunities and forecast in blastomycosis medicine market in Canada to 2035 by type (azole antifungals, echinocandins, and polyenes) and application (hospitals, clinics, homecare, pharmacies, and research institutes)

This market report covers trends, opportunities and forecasts in ganirelix market in Canada to 2031 by type (original drugs and generic drugs) and application (hospital, pharmacy, and others)

This market report covers trends, opportunities, and forecasts in the comparator drug sourcing market in Canada to 2031 by type (local sourcing, central sourcing, and others), and application (drug producers/manufacturers, CMO, academic & research institu

This market report covers trends, opportunities and forecasts in aripiprazole drug market in Canada to 2031 by type (tablets, injection, and others), and application (adult patients and pediatric patients)

This market report covers trends, opportunities and forecasts in sulfonylurea hypoglycemic drug market in Canada to 2031 by type (first generation sulfonylureas, second generation sulfonylureas, and third generation sulfonylureas) and application (hospita

This market report covers trends, opportunities, and forecasts in the Zika virus vaccine market in Canada to 2031 by type (therapeutic vaccines and preventive vaccines), and end use (hospitals, clinics, research institutes, and others)

This market report covers trends, opportunities, and forecasts in the ginseng health product market in Canada to 2031 by type (powder, slice, capsule, and others), and application (online sales and offline sales)

This market report covers trends, opportunities, and forecasts in the drug discovery outsourcing market in Canada to 2031 by drug type (small molecules and large molecules), workflow (target identification & screening, target validation & functional informatics, lead identification & candidate optimization, preclinical development, and other associated workflow), therapeutic area (cardiovascular, central nervous system (CNS), gastrointestinal, hematology, respiratory system, infectious disease, oncology, immunology, and others), and end use (pharmaceutical and biotechnology companies, academic institutes, and others)

This market report covers trends, opportunities, and forecasts in the chikungunya vaccine market in Canada to 2031 by type (live-attenuated virus vaccines, inactivated viral vaccines, chimeric-alphavirus candidates, recombinant viral vaccines, and others), age group (paediatric, adult, and geriatric), and end use (hospital pharmacies, retail pharmacies, and others)

This market report covers trends, opportunities, and forecasts in the toxicology drug screening market in Canada to 2031 by technology (high-throughput screening, genomics, transcriptomics, toxicogenomics, and molecular screening), type (cardiovascular disease drug screening, obesity drug screening, diabetes drug screening, and others), test type (acute systemic toxicity, dermal toxicity, carcinogenicity, ocular toxicity, genotoxicity, neurotoxicity, and organ-specific toxicity), and end use (hospitals and trauma centers, forensic laboratories, diagnostic laboratories, rehabilitation centers, and pharmaceutical & biotechnology companies)

This market report covers trends, opportunities, and forecasts in the avian influenza vaccine market in Canada to 2031 by strain type (H5, H9, H7, and others), type (inactivated, live attenuated, recombinant, vector-based, and others), and application (chicken, duck, goose, turkey, quail, and others)

This market report covers trends, opportunities, and forecasts in the animal vaccine market in Canada to 2031 by product (attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, recombinant vaccines, and DNA vaccines), and animal type (companion animal, livestock animal, and aquaculture)

This market report covers trends, opportunities, and forecasts in the tetanus toxoid vaccine market in Canada to 2031 by type (monovalent tetanus toxoid, tetanus-diphtheria, diphtheria, tetanus, & pertussis, and others), form (quadrivalent, pentavalent, and hexavalent), and end use (hospitals & clinics, government organisations, and others)

This market report covers trends, opportunities, and forecasts in the meningococcal vaccine market in Canada to 2031 by type (polysaccharide, conjugate vaccines, combination vaccines, men B vaccines, and others), and end use (retail pharmacies, hospital pharmacies, and others)

This market report covers trends, opportunities, and forecasts in the measles vaccine market in Canada to 2031 by type (mumps measles rubella vaccine and live mmr-II), application (pediatric population, adolescent population, and adult population), and en

This market report covers trends, opportunities, and forecasts in the rotavirus vaccine market in Canada to 2031 by type (Rotarix, rotateq, rotavin-m1, lanzhou lamb, and others), and end use (hospitals and clinics, academic and research, and others)

This market report covers trends, opportunities, and forecasts in the ashwagandha extract market in Canada to 2031 by form (powder, capsules/tablets, and others), distribution channel (business to business and business to consumer), and application (sports nutrition, food and beverages, dietary supplements, and others)

This market report covers trends, opportunities, and forecasts in the imatinib drug market in Canada to 2031 by drug formulation (capsules and tablets) and application (philadelphia positive chronic myeloid leukemia, hyper-eosinophilic syndrome (HES), myelodysplastic syndrome (MDS), myeloproliferative diseases (MPD), and gastrointestinal stromal tumors (GIST))

This market report covers trends, opportunities, and forecasts in the nucleic acid drug market in Canada to 2031 by type (antisense nucleic acid drugs, SiRNA drugs, SaRNA drugs, MiRNA drugs, MRNA drugs, and others) and application (genetic disease, cancer, cardiovascular diseases, and others)

This market report covers trends, opportunities, and forecasts in the psychotropic drug market in Canada to 2031 by drug type (chlorpromazine, thioridazine, quetiapine, risperidone, clozapine, paroxetine, fluvoxam, and others), application (anti-psychotics, antidepressants, mood stabilizers, anti-anxiety, antiepileptic drugs, hypnotics, and stimulants), and end use (hospital pharmacies, retail pharmacies, online pharmacies, drug stores, and others)

Trends, opportunity and forecast in remdesivir market in Canada to 2030 by dosage (2.5mg, 5mg, 100mg, and 200mg), form (lyophilized powder and concentrated solution), application (ebola, sars-cov, and mers-cov), and distribution channel (hospital pharmacy, retail pharmacy, and online pharmacy).

Trends, opportunity and forecast in morphine market in Canada to 2030 by dosage form (injection, oral tablets, and others), distrbution channel (hospital pharmacies, retail pharmacies, online pharmacies, and others), application (pain management, diarrhea suppressant, cold and cough suppressant, and others), and end use (hospitals & clinics, ambulatory surgical centers, and others).

Trends, opportunity and forecast in olanzapine market in Canada to 2030 by route of administration (oral and parenteral) and application (bipolar disorder, schizophrenia, and others).

Trends, opportunity and forecast in rosacea treatment market in Canada to 2030 by drug class (antibiotics, alpha agonists, retinoids,corticosteroids, immunosuppressants, antihypertensive agents, and others), and mode of administration (topical and oral)

Trends, opportunity and forecast in keloid treatment market in Canada to 2030 by treatment (occlusive dressing, compression therapy, cryosurgery,excision, radiation therapy, laser therapy, interferon therapy, intralesional corticosteroid injections, and others, ), end use industry (hospitals, dermatology clinics, ambulatory surgical centers (ASCS), and others)

Trends, opportunity and forecast in drugs of abuse testing market in Canada to 2030 by product & service (analyzers, rapid testing devices, consumables, and laboratory services), sample type (urine, hair, oral fluid, breath, and others), and end use industry (workplaces and schools, criminal justice systems and law enforcement agencies, research laboratories, and hospitals)

Trends, opportunity and forecast in osteoporosis drug market in Canada to 2030 by drug type (parathyroid hormone therapy, bisphosphonates, calcitonin, RANKL inhibitors, and others) and application (primary osteoporosis and secondary osteoporosis)

Trends, opportunity and forecast in omega 3 prescription drug market in Canada to 2030 by drug (vascepa, lovaza, and others), distribution channel (hospital pharmacy, retail pharmacy, and online pharmacy), and application (hypertriglyceridemia, high cholesterol, inflammatory bowel disease, rheumatoid arthritis, mental health conditions, neurodevelopmental disorders, and others).

Trends, opportunity and forecast in in-silico drug discovery market in Canada to 2030 by type (software as a service, consultancy as a service, and software), target therapeutic area (human immunodeficiency virus (HIV), infectious diseases, metabolic disorders, mental disorders, musculoskeletal disorders, neurological disorders, oncological disorders, respiratory disorders, and others), workflow (discovery, target identification, reverse docking, bioinformatics, protein structure prediction, target validation, lead discovery, pharmacophore, and others), and end use (contract research organizations, pharmaceutical industry, academic & research institutes, and others).

Trends, opportunity and forecast in antihypertensive drug market to 2030 by therapeutic class (diuretics, ACE inhibitors, calcium channel blockers, vasodilators, beta-adrenergic blockers, and others) and distribution channel (retail pharmacy, hospital pharmacy, e-commerce, and others)

Trends, opportunity and forecast in swine vaccine market in Canad to 2030 by product (recombinant and inactivated), and disease type (classical swine fever, porcine parvovirus, swine influenza, and others).

Trends, opportunity and forecast in subunit vaccine market in Canada to 2030 by product type (protein antigen and polysaccharide antigen), and disease (infectious disease, diphtheria, tetanus and pertussis (DTP), HPV, measles, mumps and rubella (MMR), and others).

Trends, opportunity and forecast in poultry vaccine market in Canada to 2030 by product (attenuated live vaccines, inactivated vaccines, and recombinant vaccines), disease type (bronchitis, avian influenza, newcastle disease, Marek's disease, and others), and application (broiler, layer, and breeder).

Trends, opportunity and forecast in DNA vaccine market in Canada to 2030 by product type (oncept, west nile-innovator, and apex-IHN), type (therapeutic vaccines and prophylactic vaccines), and end use (veterinary clinics and veterinary hospitals).

Trends, opportunity and forecast in dengue vaccine market in Canada to 2030 by type (live attenuated vaccine, chimeric live attenuated vaccine, inactivated vaccine, subunit vaccine, and nucleic acid based vaccine), treatment (diuretic, anti-allergic, blood thinners, and others), distribution channel (hospital pharmacy, online pharmacy, and retail pharmacy), and end use (hospitals, homecare, specialty clinics, and others).

Trends, opportunity and forecast in aquaculture vaccine market in Canada to 2030 by product (inactivated vaccines and DNA vaccines), and route of administration (injected and oral).

Trends, opportunity and forecast in rubella vaccine market in Canada to 2030 by type (monovalent formulation, measles-rubella vaccine, measles, mumps, rubella vaccine, and measles mumps rubella varicella vaccine) and end use (hospitals, NGO’s, pediatric clinics, and others)

Trends, opportunity and forecast in pertussis vaccine market in Canada to 2030 by type (Dtap vaccine and Tdap vaccine) and end use (vaccination centers, hospitals, clinics, and others)

Trends, opportunity and forecast in pediatric vaccine market in Canada to 2030 by vaccine type (monovalent and multivalent), technology (live attenuated, inactivated, subunit, toxoid, conjugate, and others), and application (infectious disease, cancer, allergy, pneumococcal disease, influenza, measles, mumps, and rubella (MMR)​, and others)